慢性阻塞性肺疾病的药理管理临床实践指南

2020-09-01 Ann Am Thorac Soc . 2020 Sep 3. doi: 10.1513/AnnalsATS.202007-880CME

多学科专家小组于2020年更新了慢性阻塞性肺疾病(COPD)药理管理的循证指南(1)。 对文献进行了全面的系统回顾,以解决专家组商定的关键临床问题和以患者为中心的关键结果。 该临床摘要旨在为临床医生提

中文标题:

慢性阻塞性肺疾病的药理管理临床实践指南

英文标题:

Summary for Clinicians: Clinical Practice Guideline on Pharmacologic Management of Chronic Obstructive Pulmonary Disease

发布机构:

发布日期:

2020-09-01

简要介绍:

多学科专家小组于2020年更新了慢性阻塞性肺疾病(COPD)药理管理的循证指南(1)。 对文献进行了全面的系统回顾,以解决专家组商定的关键临床问题和以患者为中心的关键结果。 该临床摘要旨在为临床医生提供关键要点。 这些指南建议集中在稳定症状性COPD的药理管理上。 该指南对患者,临床医生和决策者有不同的含义(表1)。 当将这些指南建议应用于COPD患者的护理计划时,临床医生应始终考虑独特的个体临床情况。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=941971c0019e09f3, title=慢性阻塞性肺疾病的药理管理临床实践指南, enTitle=Summary for Clinicians: Clinical Practice Guideline on Pharmacologic Management of Chronic Obstructive Pulmonary Disease, guiderFrom=Ann Am Thorac Soc . 2020 Sep 3. doi: 10.1513/AnnalsATS.202007-880CME, authorId=0, author=, summary=多学科专家小组于2020年更新了慢性阻塞性肺疾病(COPD)药理管理的循证指南(1)。 对文献进行了全面的系统回顾,以解决专家组商定的关键临床问题和以患者为中心的关键结果。 该临床摘要旨在为临床医生提, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Sep 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>多学科专家小组于2020年更新了慢性阻塞性肺疾病(COPD)药理管理的循证指南(1)。 对文献进行了全面的系统回顾,以解决专家组商定的关键临床问题和以患者为中心的关键结果。 该临床摘要旨在为临床医生提供关键要点。 这些指南建议集中在稳定症状性COPD的药理管理上。 该指南对患者,临床医生和决策者有不同的含义(表1)。 当将这些指南建议应用于COPD患者的护理计划时,临床医生应始终考虑独特的个体临床情况。</p>, tagList=[TagDto(tagId=295, tagName=COPD)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2884, appHits=515, showAppHits=0, pcHits=598, showPcHits=2369, likes=3, shares=24, comments=42, approvalStatus=1, publishedTime=Sun Sep 13 18:28:37 CST 2020, publishedTimeString=2020-09-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sun Sep 13 18:28:32 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Thu Jan 04 01:37:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (29)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010451, encodeId=7d6e101045181, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435f5579553, createdName=ms7000001545202350, createdTime=Sun Aug 22 23:52:49 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009297, encodeId=9961100929e06, content=太好了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb55577415, createdName=ms1000000772416681, createdTime=Wed Aug 18 23:00:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976914, encodeId=c1b39e691409, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/a39f285142d84b94a82ed1c1c2fcdad5/3f800c08cdf1477c9b4bc17659447ab1.jpg, createdBy=501d5519948, createdName=ms4000000459792702, createdTime=Fri Jun 25 22:40:52 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924277, encodeId=db239242e748, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Fri Feb 12 14:38:23 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918245, encodeId=e03a918245e6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5e15451195, createdName=ms5000002086959067, createdTime=Wed Jan 20 01:44:46 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-08-22 ms7000001545202350

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010451, encodeId=7d6e101045181, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435f5579553, createdName=ms7000001545202350, createdTime=Sun Aug 22 23:52:49 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009297, encodeId=9961100929e06, content=太好了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb55577415, createdName=ms1000000772416681, createdTime=Wed Aug 18 23:00:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976914, encodeId=c1b39e691409, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/a39f285142d84b94a82ed1c1c2fcdad5/3f800c08cdf1477c9b4bc17659447ab1.jpg, createdBy=501d5519948, createdName=ms4000000459792702, createdTime=Fri Jun 25 22:40:52 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924277, encodeId=db239242e748, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Fri Feb 12 14:38:23 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918245, encodeId=e03a918245e6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5e15451195, createdName=ms5000002086959067, createdTime=Wed Jan 20 01:44:46 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-08-18 ms1000000772416681

    太好了,感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010451, encodeId=7d6e101045181, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435f5579553, createdName=ms7000001545202350, createdTime=Sun Aug 22 23:52:49 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009297, encodeId=9961100929e06, content=太好了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb55577415, createdName=ms1000000772416681, createdTime=Wed Aug 18 23:00:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976914, encodeId=c1b39e691409, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/a39f285142d84b94a82ed1c1c2fcdad5/3f800c08cdf1477c9b4bc17659447ab1.jpg, createdBy=501d5519948, createdName=ms4000000459792702, createdTime=Fri Jun 25 22:40:52 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924277, encodeId=db239242e748, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Fri Feb 12 14:38:23 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918245, encodeId=e03a918245e6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5e15451195, createdName=ms5000002086959067, createdTime=Wed Jan 20 01:44:46 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-06-25 ms4000000459792702

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010451, encodeId=7d6e101045181, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435f5579553, createdName=ms7000001545202350, createdTime=Sun Aug 22 23:52:49 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009297, encodeId=9961100929e06, content=太好了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb55577415, createdName=ms1000000772416681, createdTime=Wed Aug 18 23:00:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976914, encodeId=c1b39e691409, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/a39f285142d84b94a82ed1c1c2fcdad5/3f800c08cdf1477c9b4bc17659447ab1.jpg, createdBy=501d5519948, createdName=ms4000000459792702, createdTime=Fri Jun 25 22:40:52 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924277, encodeId=db239242e748, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Fri Feb 12 14:38:23 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918245, encodeId=e03a918245e6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5e15451195, createdName=ms5000002086959067, createdTime=Wed Jan 20 01:44:46 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-02-12 ddrrrr13

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1010451, encodeId=7d6e101045181, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=435f5579553, createdName=ms7000001545202350, createdTime=Sun Aug 22 23:52:49 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009297, encodeId=9961100929e06, content=太好了,感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfb55577415, createdName=ms1000000772416681, createdTime=Wed Aug 18 23:00:28 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976914, encodeId=c1b39e691409, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/a39f285142d84b94a82ed1c1c2fcdad5/3f800c08cdf1477c9b4bc17659447ab1.jpg, createdBy=501d5519948, createdName=ms4000000459792702, createdTime=Fri Jun 25 22:40:52 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924277, encodeId=db239242e748, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/deb9cbd849f8496eb91e945a9b30c8c9/47210eaeb9a14963a5f35bdd95998a3c.jpg, createdBy=85962545734, createdName=ddrrrr13, createdTime=Fri Feb 12 14:38:23 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918245, encodeId=e03a918245e6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5e15451195, createdName=ms5000002086959067, createdTime=Wed Jan 20 01:44:46 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-20 ms5000002086959067

    0